Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Hamme-Mille – page 71

1 947 clinical trials in Hamme-Mille, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Hamme-Mille at a glance
1 947
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 947 trials in Hamme-Mille

Open in trial search

Uveal melanoma

Not yet recruiting

Study of Darovasertib and Crizotinib for Patients with HLA-A2 Negative Metastatic Uveal Melanoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Crizotinib
  • Sponsor:Ideaya Biosciences Inc.

Hypertrophic cardiomyopathy

Not yet recruiting

Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

Aortic valve replacement

Not yet recruiting

Study on High vs. Low Dose Bupivacaine Hydrochloride and Epinephrine for Pain Relief After Aortic Valve Replacement Surgery

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Epinephrine
  • Sponsor:Jessa Ziekenhuis

Acute myeloid leukaemia

Not yet recruiting

Study of venetoclax and mercaptopurine combination treatment for patients with relapsed or treatment-resistant acute myeloid leukemia

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mercaptopurine
  • Sponsor:Antwerp University Hospital

Glioblastoma

Not yet recruiting

Study on Lomustine with or without Additional Brain Radiation for Patients with Recurrent Glioblastoma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Lomustine
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Hypophosphatasia

Not yet recruiting

Study of ALXN1850 for Children Aged 2 to 12 with Hypophosphatasia Who Have Not Previously Received Asfotase Alfa Treatment

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:ALXN1850
  • Sponsor:Alexion Pharmaceuticals Inc.

Non-small cell lung cancer

Not yet recruiting

Study to Compare Zongertinib with Standard Treatment for Patients with Advanced Non-Small Cell Lung Cancer with HER2 Mutations

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study on Obeticholic Acid for Children with Biliary Atresia After Kasai Procedure

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Obeticholic Acid
  • Sponsor:Intercept Pharmaceuticals Inc.

Follicular lymphoma

Not yet recruiting

Study on Mosunetuzumab and Lenalidomide for Untreated Follicular Lymphoma Patients

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Mosunetuzumab
  • Sponsor:F. Hoffmann-La Roche AG

Non-small cell lung cancer+1

Not yet recruiting

Study of SYM024, SYM023, and SYM025 in Adults with Advanced Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Expression

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Institut De Recherches Internationales Servier IRIS

Neoplasm malignant

Not yet recruiting

Study on the Effectiveness and Safety of Luveltamab Tazevibulin Compared to Chemotherapy in Women with Relapsed Platinum-resistant Ovarian Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Sutro Biopharma Inc.

Fallopian tube cancer+1

Not yet recruiting

Study of Mirvetuximab Soravtansine and Bevacizumab for Maintenance in Adults with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Hamme-Mille

What the registry says about research in the country

01 Viral Infections & Dermatology

Clinical research focusing on recurrent orofacial herpes and non-genital wart treatments, evaluating innovative therapeutic approaches for common viral skin conditions.

  • Herpes Management Study
  • Wart Treatment Evaluation

These trials aim to assess the effectiveness of specialized treatments in reducing infection recurrence and promoting lesion clearance.

02 Treatment Efficacy Studies

Comprehensive evaluation of therapeutic interventions through placebo-controlled trials, focusing on long-term effectiveness and patient outcomes.

  • 12-month Episode Reduction Analysis
  • Comparative Treatment Assessment

Research protocols designed to measure treatment success rates and duration of therapeutic effects.

03 Clinical Research Methodology

Implementation of double-blind randomized studies to ensure unbiased evaluation of treatment efficacy in dermatological conditions.

  • Placebo-Controlled Protocols
  • Treatment Duration Analysis

Structured research approaches examining both pediatric and adult treatment formulations.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.